ADCs in the Treatment of Breast Cancer and Gastric Cancer and Managing AEs Associated with ADCs - Episode 1

Patient Profile 1: A Patient With HER2+ Metastatic BC Treated With T-DXd who Develops ILD

, , ,

After reviewing the historical use of ADCs, panelists discuss the first patient profile of HER2+ metastatic breast cancer managed with trastuzumab deruxtecan.